Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia

Despite the rapid development of medicine, even nowadays, acute lymphoblastic leukemia (ALL) is still a problem for pediatric clinicians. Modern medicine has reached a limit of curability even though the recovery rate exceeds 90%. Relapse occurs in around 20% of treated patients and, regrettably, 10...

Descripción completa

Detalles Bibliográficos
Autores principales: Jędraszek, Krzysztof, Malczewska, Marta, Parysek-Wójcik, Karolina, Lejman, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950780/
https://www.ncbi.nlm.nih.gov/pubmed/35328487
http://dx.doi.org/10.3390/ijms23063067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950780/
https://www.ncbi.nlm.nih.gov/pubmed/35328487
http://dx.doi.org/10.3390/ijms23063067

Ejemplares similares